AAPL336.64-3.78 (-1.11%) ▼|ABBV276.47+4.05 (+1.49%) ▲|ABT99.60+1.11 (+1.13%) ▲|ACN209.06+0.70 (+0.34%) ▲|ADBE242.27+1.22 (+0.51%) ▲|AMAT507.03-2.54 (-0.50%) ▼|AMD608.10-12.58 (-2.03%) ▼|AMGN414.87+7.43 (+1.82%) ▲|AMT182.24+15.51 (+9.30%) ▲|AMZN262.43+8.37 (+3.29%) ▲|AVGO361.54+1.40 (+0.39%) ▲|AXP308.17+1.02 (+0.33%) ▲|BA190.37+2.62 (+1.40%) ▲|BAC54.32+0.71 (+1.32%) ▲|BKNG160.34+0.37 (+0.23%) ▲|BLK1,082.39+17.04 (+1.60%) ▲|BMY59.12-0.46 (-0.77%) ▼|BNY142.71-0.90 (-0.63%) ▼|BRK-B515.62+4.57 (+0.89%) ▲|C129.64+1.56 (+1.22%) ▲|CAT800.47+4.29 (+0.54%) ▲|CL88.27+0.17 (+0.19%) ▲|CMCSA20.66-0.55 (-2.59%) ▼|COF199.26-0.14 (-0.07%) ▼|COP134.10-0.09 (-0.07%) ▼|COST946.92-1.00 (-0.11%) ▼|CRM229.13+1.33 (+0.58%) ▲|CSCO118.39+3.50 (+3.05%) ▲|CVS86.16-1.64 (-1.87%) ▼|CVX211.98+0.43 (+0.20%) ▲|DE620.93-31.65 (-4.85%) ▼|DHR219.81+2.35 (+1.08%) ▲|DIS108.05+1.03 (+0.96%) ▲|DUK116.65-0.19 (-0.16%) ▼|EMR161.83+2.77 (+1.74%) ▲|FDX291.71-0.02 (-0.01%) ▼|GD331.27+2.96 (+0.90%) ▲|GE308.20+2.58 (+0.84%) ▲|GEV1,004.73+5.38 (+0.54%) ▲|GILD151.17+4.07 (+2.77%) ▲|GM82.73+0.48 (+0.58%) ▲|GOOG347.86+3.00 (+0.87%) ▲|GOOGL351.66+3.37 (+0.97%) ▲|GS895.32+12.73 (+1.44%) ▲|HD290.74-4.73 (-1.60%) ▼|HON207.73+1.13 (+0.55%) ▲|IBM227.13+0.52 (+0.23%) ▲|INTC104.70-2.38 (-2.22%) ▼|INTU302.75-1.13 (-0.37%) ▼|ISRG423.96+8.55 (+2.06%) ▲|JNJ261.44+4.96 (+1.93%) ▲|JPM332.99+1.57 (+0.47%) ▲|KO88.05+0.28 (+0.32%) ▲|LIN483.73+2.03 (+0.42%) ▲|LLY1,179.27+9.67 (+0.83%) ▲|LMT509.59+1.70 (+0.33%) ▲|LOW186.00-2.85 (-1.51%) ▼|LRCX318.84-1.75 (-0.55%) ▼|MA589.14+15.25 (+2.66%) ▲|MCD235.23-1.67 (-0.70%) ▼|MDLZ60.41-0.26 (-0.43%) ▼|MDT88.48+0.73 (+0.83%) ▲|META718.67-2.22 (-0.31%) ▼|MMM159.96-3.62 (-2.21%) ▼|MO71.68+0.26 (+0.36%) ▲|MRK145.60+3.22 (+2.26%) ▲|MS190.02+2.58 (+1.38%) ▲|MSFT535.07+12.46 (+2.38%) ▲|MU1,029.00-6.84 (-0.66%) ▼|NEE77.38+0.01 (+0.01%) ▲|NFLX70.30-1.27 (-1.77%) ▼|NKE34.71-0.03 (-0.09%) ▼|NOW140.86+1.11 (+0.79%) ▲|NVDA229.28-1.20 (-0.52%) ▼|ORCL141.40+6.21 (+4.59%) ▲|PEP125.97-2.37 (-1.85%) ▼|PFE28.28+0.46 (+1.65%) ▲|PG151.23+0.64 (+0.43%) ▲|PLTR209.05+10.27 (+5.17%) ▲|PM201.19+0.69 (+0.34%) ▲|QCOM175.50-0.51 (-0.29%) ▼|RTX185.97+1.65 (+0.90%) ▲|SBUX90.75-2.46 (-2.64%) ▼|SCHW96.70-0.17 (-0.18%) ▼|SO86.17+0.02 (+0.02%) ▲|SPG199.42-0.19 (-0.10%) ▼|T22.18-2.41 (-9.81%) ▼|TMO658.02+6.04 (+0.93%) ▲|TMUS148.58-22.73 (-13.27%) ▼|TSLA382.70+7.70 (+2.05%) ▲|TXN283.74-4.46 (-1.55%) ▼|UBER71.51+1.27 (+1.81%) ▲|UNH379.30+8.35 (+2.25%) ▲|UNP278.34+0.14 (+0.05%) ▲|UPS94.57+0.44 (+0.47%) ▲|USB57.08+0.05 (+0.09%) ▲|V385.45+10.35 (+2.76%) ▲|VZ41.65-3.99 (-8.75%) ▼|WFC83.55+1.52 (+1.85%) ▲|WMT111.35+0.79 (+0.71%) ▲|XOM168.94+0.44 (+0.26%) ▲|AAPL336.64-3.78 (-1.11%) ▼|ABBV276.47+4.05 (+1.49%) ▲|ABT99.60+1.11 (+1.13%) ▲|ACN209.06+0.70 (+0.34%) ▲|ADBE242.27+1.22 (+0.51%) ▲|AMAT507.03-2.54 (-0.50%) ▼|AMD608.10-12.58 (-2.03%) ▼|AMGN414.87+7.43 (+1.82%) ▲|AMT182.24+15.51 (+9.30%) ▲|AMZN262.43+8.37 (+3.29%) ▲|AVGO361.54+1.40 (+0.39%) ▲|AXP308.17+1.02 (+0.33%) ▲|BA190.37+2.62 (+1.40%) ▲|BAC54.32+0.71 (+1.32%) ▲|BKNG160.34+0.37 (+0.23%) ▲|BLK1,082.39+17.04 (+1.60%) ▲|BMY59.12-0.46 (-0.77%) ▼|BNY142.71-0.90 (-0.63%) ▼|BRK-B515.62+4.57 (+0.89%) ▲|C129.64+1.56 (+1.22%) ▲|CAT800.47+4.29 (+0.54%) ▲|CL88.27+0.17 (+0.19%) ▲|CMCSA20.66-0.55 (-2.59%) ▼|COF199.26-0.14 (-0.07%) ▼|COP134.10-0.09 (-0.07%) ▼|COST946.92-1.00 (-0.11%) ▼|CRM229.13+1.33 (+0.58%) ▲|CSCO118.39+3.50 (+3.05%) ▲|CVS86.16-1.64 (-1.87%) ▼|CVX211.98+0.43 (+0.20%) ▲|DE620.93-31.65 (-4.85%) ▼|DHR219.81+2.35 (+1.08%) ▲|DIS108.05+1.03 (+0.96%) ▲|DUK116.65-0.19 (-0.16%) ▼|EMR161.83+2.77 (+1.74%) ▲|FDX291.71-0.02 (-0.01%) ▼|GD331.27+2.96 (+0.90%) ▲|GE308.20+2.58 (+0.84%) ▲|GEV1,004.73+5.38 (+0.54%) ▲|GILD151.17+4.07 (+2.77%) ▲|GM82.73+0.48 (+0.58%) ▲|GOOG347.86+3.00 (+0.87%) ▲|GOOGL351.66+3.37 (+0.97%) ▲|GS895.32+12.73 (+1.44%) ▲|HD290.74-4.73 (-1.60%) ▼|HON207.73+1.13 (+0.55%) ▲|IBM227.13+0.52 (+0.23%) ▲|INTC104.70-2.38 (-2.22%) ▼|INTU302.75-1.13 (-0.37%) ▼|ISRG423.96+8.55 (+2.06%) ▲|JNJ261.44+4.96 (+1.93%) ▲|JPM332.99+1.57 (+0.47%) ▲|KO88.05+0.28 (+0.32%) ▲|LIN483.73+2.03 (+0.42%) ▲|LLY1,179.27+9.67 (+0.83%) ▲|LMT509.59+1.70 (+0.33%) ▲|LOW186.00-2.85 (-1.51%) ▼|LRCX318.84-1.75 (-0.55%) ▼|MA589.14+15.25 (+2.66%) ▲|MCD235.23-1.67 (-0.70%) ▼|MDLZ60.41-0.26 (-0.43%) ▼|MDT88.48+0.73 (+0.83%) ▲|META718.67-2.22 (-0.31%) ▼|MMM159.96-3.62 (-2.21%) ▼|MO71.68+0.26 (+0.36%) ▲|MRK145.60+3.22 (+2.26%) ▲|MS190.02+2.58 (+1.38%) ▲|MSFT535.07+12.46 (+2.38%) ▲|MU1,029.00-6.84 (-0.66%) ▼|NEE77.38+0.01 (+0.01%) ▲|NFLX70.30-1.27 (-1.77%) ▼|NKE34.71-0.03 (-0.09%) ▼|NOW140.86+1.11 (+0.79%) ▲|NVDA229.28-1.20 (-0.52%) ▼|ORCL141.40+6.21 (+4.59%) ▲|PEP125.97-2.37 (-1.85%) ▼|PFE28.28+0.46 (+1.65%) ▲|PG151.23+0.64 (+0.43%) ▲|PLTR209.05+10.27 (+5.17%) ▲|PM201.19+0.69 (+0.34%) ▲|QCOM175.50-0.51 (-0.29%) ▼|RTX185.97+1.65 (+0.90%) ▲|SBUX90.75-2.46 (-2.64%) ▼|SCHW96.70-0.17 (-0.18%) ▼|SO86.17+0.02 (+0.02%) ▲|SPG199.42-0.19 (-0.10%) ▼|T22.18-2.41 (-9.81%) ▼|TMO658.02+6.04 (+0.93%) ▲|TMUS148.58-22.73 (-13.27%) ▼|TSLA382.70+7.70 (+2.05%) ▲|TXN283.74-4.46 (-1.55%) ▼|UBER71.51+1.27 (+1.81%) ▲|UNH379.30+8.35 (+2.25%) ▲|UNP278.34+0.14 (+0.05%) ▲|UPS94.57+0.44 (+0.47%) ▲|USB57.08+0.05 (+0.09%) ▲|V385.45+10.35 (+2.76%) ▲|VZ41.65-3.99 (-8.75%) ▼|WFC83.55+1.52 (+1.85%) ▲|WMT111.35+0.79 (+0.71%) ▲|XOM168.94+0.44 (+0.26%) ▲|
14.4 C
New York
Saturday, October 10, 2026

Tag: rights

VIZSLA SILVER ANNOUNCES RESULTS OF ANNUAL GENERAL AND SPECIAL MEETING

VANCOUVER, BC, Oct. 9, 2026 /PRNewswire/ -- Vizsla Silver Corp. (TSX: VZLA) (NYSE: VZLA) (Frankfurt: 0G31) ("Vizsla Silver" or the "Company") is pleased to...

VIZSLA SILVER ANNOUNCES RESULTS OF ANNUAL GENERAL AND SPECIAL MEETING

VANCOUVER, BC, Oct. 9, 2026 /CNW/ -- Vizsla Silver Corp. (TSX: VZLA) (NYSE: VZLA) (Frankfurt: 0G31) ("Vizsla Silver" or the "Company") is pleased to...

CITY JAM Founder Pat Villaceran Launches an AI-Era Accelerator and Incubator Model for Music, Starting With Record Labels

The music industry spent years making it easier to create and distribute music. CITY JAM founder Pat Villaceran is betting that the next opportunity...

Egan-Jones Examines French Proposal to Cancel Central Bank Debt Holdings

NEW YORK, Oct. 9, 2026 /PRNewswire/ -- Egan-Jones released an analysis examining a proposal that France cancel the government debt held by its central bank,...

Siteimprove Named a Leader in the 2026 Gartner® Magic Quadrant™ for Digital Accessibility

Recognized for Completeness of Vision and Ability to ExecuteCOPENHAGEN, Denmark, Oct. 9, 2026 /PRNewswire/ -- We are excited to share that Siteimprove has been...

Siteimprove Named a Leader in the 2026 Gartner® Magic Quadrant™ for Digital Accessibility

Recognized for Completeness of Vision and Ability to ExecuteCOPENHAGEN, Denmark, Oct. 9, 2026 /PRNewswire/ -- We are excited to share that Siteimprove has been...

HeyGen Launches HeyGen Voice, Debuting at #1 on Artificial Analysis’ Leaderboard

HeyGen Supports High-Quality, Identity-Secure Video Content Creation for Creators and Businesses at ScaleHeyGen Voice Delivers Authentic, Natural Output That Sounds Like the User's Real...

Bitty & Beau’s Coffee Seeks New Franchise Owners as Mobile Coffee Business Expands Nationwide

With eight Cruisers operating, eight more in production and dozens of additional opportunities in development, the nationally recognized coffee brand is inviting entrepreneurs to...

SciBase’s rights issue registered, conversion of BTA into shares

STOCKHOLM, Oct. 9, 2026 /PRNewswire/ -- SciBase Holding AB (publ) ("SciBase" or the "Company") announces that the rights issue of shares of approximately SEK...

New Johnson & Johnson ICOTYDE® (icotrokinra) long-term data demonstrate robust 2-year results in the treatment of adults and adolescents with plaque psoriasis

Phase 3 data presented at Fall Clinical Dermatology show high, sustained response rates in adults and adolescents, with nearly three-quarters achieving clear or almost...

Boliden’s Nomination Committee for the 2027 Annual General Meeting

STOCKHOLM, Oct. 9, 2026 /PRNewswire/ -- Under the instructions adopted by Boliden AB's Annual General Meeting, and subject to their willingness to participate, Boliden's Nomination...

Prifemilast Demonstrates Superior Efficacy vs. Apremilast in Newsoara’s Head-to-Head Phase 3 Psoriasis Trial; cAMPfield Advancing the Potential Best-in-Class Oral PDE4 Inhibitor in IBD

In a head-to-head Phase 3 trial, prifemilast nearly doubled the rate of PASI 75 response compared with apremilast and achieved superiority on both co-primary...

TORM plc Announces Change to the Board

HELLERUP, Denmark, Oct. 9, 2026 /PRNewswire/ -- TORM plc (NASDAQ: TRMD) (NASDAQ: TRMD A) announces that, following Oaktree Capital Management and its affiliates no...

EQT AB’s Nomination Committee for the Annual Shareholders’ Meeting 2027

STOCKHOLM, Oct. 9, 2026 /PRNewswire/ -- EQT AB's Nomination Committee for the Annual Shareholders' Meeting 2027 has been appointed based on the ownership structure...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRights